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Purpose: To assess the reproducibility of percentage ventilated lung volume (%VV) 
measurements in healthy volunteers acquired by fluorine (19F)-MRI of inhaled per-
fluoropropane, implemented at two research sites.
Methods: In this prospective, ethically approved study, 40 healthy participants were 
recruited (May 2018-June 2019) to one of two research sites. Participants underwent 
a single MRI scan session on a 3T scanner, involving periodic inhalation of a 79% 
perfluoropropane/21% oxygen gas mixture. Each gas inhalation session lasted about 
30 seconds, consisting of three deep breaths of gas followed by a breath-hold. Four 
19F-MR ventilation images were acquired per participant, each separated by approxi-
mately 6 minutes. The value of %VV was determined by registering separately ac-
quired 1H images to ventilation images before semi-automated image segmentation, 
performed independently by two observers. Reproducibility of %VV measurements 
was assessed by components of variance, intraclass correlation coefficients, coef-
ficients of variation (CoV), and the Dice similarity coefficient.
Results: The MRI scans were well tolerated throughout, with no adverse events. 
There was a high degree of consistency in %VV measurements for each participant 
(CoVobserver1 = 0.43%; CoVobserver2 = 0.63%), with overall precision of %VV meas-
urements determined to be within ± 1.7% (95% confidence interval). Interobserver 
agreement in %VV measurements revealed a high mean Dice similarity coefficient 
(SD) of 0.97 (0.02), with only minor discrepancies between observers.
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1 |  INTRODUCTION
Magnetic resonance imaging is an attractive approach to 
the investigation of respiratory disease, given its nonin-
vasive nature and lack of exposure to ionizing radiation. 
Conventional MRI of the lungs remains challenging, how-
ever, due primarily to the low proton density of lung tissue 
and magnetic field inhomogeneities that exist at ubiquitous 
air–tissue interfaces.1 The use of exogenous gas agents can 
overcome these challenges by direct visualization of in-
haled gas within the lungs, enabling assessment of regional 
ventilation properties. Specifically, hyperpolarized-gas 
MRI (HP-MRI) is well established in research settings2,3 
and has led to the development of novel imaging biomark-
ers relating to lung function.4-6 Of these, the percentage 
ventilated lung volume (%VV) and related ventilation de-
fect percentage have been reported widely,7,8 providing 
clinically useful metrics of ventilatory function that cor-
relate strongly with conventional spirometric indices.9,10 
Previous studies have established the reproducibility of 
these HP-MRI measurements in healthy volunteers7,9,11 and 
patients with respiratory disease,11-14 showing improved 
sensitivity to early smoking-related disease15 and asthma 
control16 compared with spirometry. However, the require-
ment for specialized polarizing equipment and expertise 
remains a potential barrier to widespread clinical adoption 
of this technique.
The 19F-MRI of inhaled perfluoropropane (PFP) offers an 
alternative approach to human lung imaging, with potential 
to provide similar functional information regarding pulmo-
nary ventilation to HP-MRI.17 Crucially, this technique uses 
an inert gas that can be mixed with oxygen and imaged at 
thermal polarization, thus avoiding the need for hyperpo-
larization. A small number of studies have demonstrated 
feasibility of this method to assess regional gas distribu-
tion in healthy volunteers18-21 and patients with respiratory 
disease,19,22-24 building on an extensive body of preclinical 
work.25-32 The ability to breathe PFP over the course of sev-
eral respiratory cycles offers further scope to acquire dy-
namic measurements of gas distribution, which has recently 
shown promise for evaluating airflow limitation in chronic 
obstructive pulmonary disease.22,33 Nonetheless, pulmonary 
19F-MRI remains in relative infancy, and, to date, no studies 
have evaluated the utility of %VV measurements using this 
approach. Determining the capability of static 19F-MR venti-
lation imaging to accurately report on such lung biomarkers 
in healthy volunteers is a necessary precursor to performing 
downstream patient studies. Moreover, the implementation of 
19F-MRI scan procedures at more than one study site serves 
to define a baseline standard for robust application of future 
dynamic 19F-MRI protocols.
The purpose of this study was to assess the utility of static 
19F-MR ventilation imaging by determining the interscan 
and interobserver reproducibility of %VV measurements in 
healthy participants across two research sites.
2 |  METHODS
This prospective, dual-center study was approved by the 
local research ethics committee (Ref 16/NE/0282) and the 
National Health Service Health Research Authority.
2.1 | Study population
Forty healthy participants (21 males, 19 females; ages 23-67 
years, mean = 41) provided written informed consent and 
were screened for eligibility at one of two UK study sites (20 
at Newcastle [site A]; 20 at Sheffield [site B]) between May 
2018 and June 2019. Participants were recruited from local 
university and health care institutions at respective study sites 
through poster and/or email advertisement. All participants 
were nonsmokers in good health, with normal lung function 
as assessed by spirometry.34 Study inclusion and exclusion 
criteria are summarized in Table 1.
2.2 | Magnetic resonance imaging
Participants underwent a single MRI scan session at one of 
the two study sites. All scans were performed supine using a 
Philips Achieva (site A) or Philips Ingenia (site B) 3T scanner 
(Philips Healthcare, Guildford, United Kingdom) interfaced 
to a 19F/1H chest birdcage coil (Rapid Biomedical, Rimpar, 
Germany). Anatomical 1H scans were acquired after instructing 
Conclusion: We demonstrate good reproducibility of %VV measurements in a group 
of healthy participants using 19F-MRI of inhaled perfluoropropane. Our methods 
have been successfully implemented across two different study sites, supporting the 
feasibility of performing larger multicenter clinical studies.
K E Y W O R D S
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participants to perform a breath-hold at maximal inspiration, 
using a 3D spoiled gradient-echo sequence (Table 2).
Participants were subsequently instructed to inhale a 
79% PFP/21% oxygen gas mixture (BOC Special Products, 
Guildford, United Kingdom) on five occasions during the MRI 
scan session (Figure 1). Each gas inhalation session lasted ap-
proximately 30 seconds, consisting of three deep breaths of gas 
from a starting point of relaxed end-expiration, followed by a 
breath-hold (13.4 seconds) at maximal inspiration. Participants 
were coached in the inhalation scheme before entering the MRI 
scanner, and instructions were reiterated before each gas inha-
lation session to ensure compliance with breathing maneuvers. 
All gas inhalations were performed according to verbal breath-
ing instructions provided by the attending MR radiographer. 
The PFP/oxygen gas mixture was administered from a 25-L 
reservoir bag with plastic tubing combined with a manually op-
erated three-way gas switch, non-rebreathe valve, and mouth-
piece (Hans Rudolf, Shawnee, Kansas).
An FID whole-lung spectroscopy scan (Table 2) was ac-
quired at the onset of breath-hold during the first gas inhalation 
session, allowing measurement of PFP’s -CF3 
19F resonant 
frequency. A 3D spoiled gradient-echo sequence (Table 2) 
was acquired at the onset of breath-hold for the remaining 
four gas inhalation sessions, enabling acquisition of four 3D 
19F-MR ventilation images per participant. Each 19F-MRI 
acquisition was separated by an interval of approximately 6 
minutes (mean [SD] = 358 [74] seconds), ensuring substan-
tial gas washout from the lungs between acquisitions. Heart 
rate and oxygen saturations were monitored throughout using 
an MR-compatible pulse oximeter (Nonin Medical, Plymouth, 
MA). A separate supply of oxygen was available in the event of 
clinically significant desaturation (in which a sustained oxygen 
saturation below 88% would be considered an adverse event), 
and a clinician was present on site throughout all MRI scans.
2.3 | Image analysis
The MR images were analyzed independently by two observ-
ers (B.P., 3 years of MRI experience; M.N., 7 years of MRI 
experience) using in-house software35 developed in MATLAB 
(MathWorks, Natick MA) combined with open-source 3D 
segmentation functionality in ITK-SNAP.36 The 1H-MR and 
19F-MR image masks (depicting the anatomical boundaries 
of the lungs and PFP gas signal, respectively) were generated 
using ITK-SNAP’s semi-automated region-growing algorithm, 
allowing rigid registration of 1H images to each of the four 
T A B L E  1  Summary of study participant eligibility criteria
Inclusion criteria Exclusion criteria





Body weight   
50-100 kg
History of respiratory disease and/or current 
evidence of respiratory tract infection.
Cardiac or cerebrovascular disease, anemia, 
or other serious medical condition.
Current prescribed medication (excluding 
oral contraceptive).
History of smoking in past 2 years: ex-
smoker with greater than 2-pack year 
historyb and/or ex-smoker who has smoked 
for more than 2 years in total.
Contraindications to MRI (including 
incompatible body habitus/BMI greater 
than 35).
Pregnant or breastfeeding.
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in 1 
second; FVC, forced vital capacity.
aFEV1 greater than or equal to 80% predicted; FEV1/FVC greater than or equal 
to 0.7. 
b2-pack year refers to smoking 40 cigarettes per day for 1 year (1 pack = 20 
cigarettes). 
T A B L E  2  Summary of scan parameters for 1H and 19F MR acquisitions
Parameter
Scan
1H anatomical 19F FID 19F ventilation
TE (ms) 0.49 — 1.7
TR (ms) 4.0 200 7.5
Flip angle (o) 6 90 45
FOV (mm3) 440 × 440 × 247.5 — 400 × (310-360) × 250
Resolution (mm3) 3 × 3 × 7.5 — 10 × 10 × 10
Matrix size (voxels) 147 × 147 × 33 — 40 × (31-36) × 25
Bandwidth (Hz/pixel) 3400 — 500
Number of averages 1 50 3
Acquisition time (s) 14.6 10 13.4
Number of samples — 256 —
Sampling frequency (Hz) — 8000 —
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corresponding 19F-MR ventilation images. Registered images 
were subsequently segmented (Figure 2) to calculate total lung 
volumes (from 1H images) and ventilated lung volumes for 
each 19F-MR image, using a semi-automated approach as previ-
ously described.35 Distinction between ventilated and nonven-
tilated lung regions determined by the algorithm was assessed 
qualitatively by each observer and corrected manually where 
necessary, such as to amend segmentation regions where the au-
tomatic segmentation process was judged to have misassigned a 
region. This also included the removal of trachea, main bronchi, 
and major vessels from regions assigned as lung volume and 
ventilated lung volume. The value of %VV was subsequently 
calculated for each segmented image pair by dividing the ven-
tilated volume from each 19F-MR ventilation image by the total 
lung volume determined from the corresponding 1H image.
The SNR was measured for each ventilation image by 
placing a 4 × 4 cm2 region of interest in the apex of the right 
lung (signal) and a 100-cm2 region of interest below the lung 
(noise) in a central image slice, where the trachea was seen to 
bifurcate. The SNR was calculated by applying the following 
expression in MATLAB, accounting for the Rayleigh distribu-
tion of background noise in magnitude images as follows37:
2.4 | Statistical analysis
The data were analyzed by fitting linear random-effects 
models with three independent variance components: 
(
mean signal - mean noise






F I G U R E  1  Magnetic resonance imaging protocol, consisting of an initial anatomical 1H-MRI breath-hold acquisition followed by five 
fluorine (19F)-MRI breath-hold acquisitions. The first perfluoropropane (PFP) gas inhalation session was used for a whole-lung spectroscopy scan; 
the remaining four inhalation sessions were used to acquire 19F-MR ventilation images, each separated by an interval of approximately 6 minutes
F I G U R E  2  A, Registration of 1H images to 19F images, enabling correction of potential anatomical misalignment between scans. B, Semi-automated 
segmentation of individual 1H and 19F image slices, performed independently by two observers. The percentage ventilated lung volume (%VV) was 
calculated for each of the four ventilation images per participant by dividing the ventilated lung volume (VV) by the total lung volume (TLV)
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differences between participants, differences between ac-
quisitions within each participant, and differences between 
observers within each acquisition. This permitted an esti-
mation of the contribution of each individual component 
to the total variation from the true %VV. The models were 
fitted in R38 using the package lme439 and the lmer com-
mand (with formula = %VV ~ 1 participant/acquisition). 
Estimates obtained from these fits were used to compute 
intraclass correlation coefficients (ICCs) with confidence 
intervals found using the bootstrap. Coefficients of varia-
tion were computed as the SD divided by the mean over all 
repeated %VV measurements, expressed as a percentage. 
Interobserver agreement in the calculated %VV values was 
further evaluated using the Dice similarity coefficient as a 
measure of spatial overlap between segmented image pairs. 
Comparison of SNR and %VV measurements between the 
two study sites were assessed using independently sampled 
t-tests (95% confidence interval).
3 |  RESULTS
Participant demographic information is summarized in Table 3. 
The 19F-MRI scans were well tolerated throughout by all 
participants, with no adverse events. Of the 40 participants 
initially recruited to the study, a total of 38 were included 
for image analysis; 2 participants attending study site B were 
excluded from analysis as a result of poor compliance with 
breathing instructions during one or more PFP gas inhalation 
sessions, which affected the ability to make a true assessment 
of ventilated lung volumes in these participants.
3.1 | Value of %VV measurement 
reproducibility
Calculated %VV measurements for the remaining 38 study 
participants are presented in Table 4. The mean %VV value 
calculated for each participant was uniformly above 94% 
(range 94.0%-99.5%, median 98.2%).
The coefficient of variation was calculated as CoVobserver1 = 
0.43% and CoVobserver2 = 0.63%. Separate analyses by the two 
observers revealed ICCs (95% confidence interval) of 0.683 
(0.578, 0.837) for observer 1 and 0.614 (0.493, 0.784) for 
observer 2. The combined analysis of both observers gave 
components of variance for differences between participants, 
differences between acquisitions within each participant, and 
differences between observer within each acquisition of 0.90, 
0.18 and 0.54, respectively. Consequently, for a given partici-
pant, the SD of the error in a single image would be √(0.18 + 
0.54) = 0.85, such that 95% of single image estimates would 
be within ± 1.7% of the true value.
3.2 | Interobserver agreement
Figure 3A shows coronal slices from a representative 3D 19F-
MRI data set from 1 healthy participant (B2: 26-year-old fe-
male; forced expiratory volume in 1 second (FEV1) = 102% 
predicted, forced vital capacity [FVC] = 104% predicted, 
FEV1/FVC = 83%) acquired during a 13.4-second breath-
hold at maximal inspiration. Figure 3B shows orthogonal 
views from the same participant, with 19F ventilation images 
(colormap) superimposed on the corresponding anatomical 
T A B L E  3  Summary of participant demographics
Parameter Site A (n = 20) Site B (n = 18) Combined (n = 38)
Sex Male 11 9 20
Female 9 9 18
Age (years) Male 35 (23-58) 43 (28-64) 39 (23-64)
Female 43 (27-67) 42 (26-56) 43 (26-67)
Total 39 (23-67) 43 (26-64) 41 (23-67)
Body mass index (kg/m2) 24.4 (18.3-32.3) 23.3 (17-34.9) 23.9 (17-34.9)
Spirometrya FEV1 (% pred.) 105 (88-120) 100 (83-114) 103 (83-120)
FVC (% pred.) 108 (86-125) 100 (79-117) 104 (79-125)
FEV1/FVC (%) 80 (71-93) 81 (71-96) 80 (71-96)
Mean heart rate (bpm)b Pre-inhalation 70 (42-104) 65 (48-107) 68 (42-107)
Post-inhalation 72 (44-103) 67 (48-108) 70 (44-108)
Mean oxygen saturation (%) Pre-inhalation 98 (96-100) 98 (96-100) 98 (96-100)
Post-inhalation 98 (95-100) 98 (93-99) 98 (93-100)
Data are presented as mean values with range in parenthesis.
aFEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; %pred. = percentage of predicted value. 
bbpm = beats per minute. 
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1H MR images (grayscale). Homogeneous gas distribution 
can be visualized throughout the entire lung fields, with only 
minor apparent ventilation heterogeneity observed toward 
the most peripheral anterior–posterior lung slices.
The mean (SD) calculated %VV values across all analyzed 
participant data sets (N = 38) were similar between observers 
(98.2 [0.9]% and 97.8 [1.2]% for observer 1 and observer 2, re-
spectively). The random effects model estimated the variation 
about the true %VV value due to observer variation as 0.54.
Figure 4A shows a comparison of 19F-MR image segmen-
tations performed by the two observers for 1 participant (A7: 
37-year-old male; FEV1 = 113% predicted, FVC = 120% 
T A B L E  4  Calculated %VV values for study participants (N = 38)
Participant
Observer 1 Observer 2
%VV 1 %VV 2 %VV 3 %VV 4 Mean %VV %VV 1 %VV 2 %VV 3 %VV 4 Mean %VV
A1 98.0 96.9 98.6 97.4 97.7 98.9 97.2 98.9 97.8 98.2
A2 97.3 96.6 98.4 96.7 97.2 97.8 97.0 96.9 96.2 97.0
A3 98.9 98.8 98.9 98.9 98.9 98.9 98.7 97.7 98.6 98.5
A4 97.9 97.5 97.8 97.9 97.8 97.4 96.5 96.7 96.9 96.9
A5 98.6 98.2 98.8 98.8 98.6 99.7 99.2 99.1 99.1 99.2
A6 97.7 97.9 97.6 98.2 97.8 97.5 97.4 97.3 98.9 97.8
A7 98.8 99.1 98.5 98.3 98.7 98.6 98.3 98.9 97.9 98.4
A8 98.2 98.0 97.5 98.7 98.1 98.9 99.6 98.8 99.1 99.1
A9 98.1 97.8 97.7 98.1 97.9 97.9 97.4 97.1 98.1 97.6
A10 98.3 98.6 98.8 98.8 98.6 99.3 99.1 99.5 99.3 99.3
A11 97.8 97.8 98.1 98.5 98.1 97.8 97.4 98.0 97.7 97.7
A12 98.5 98.6 98.9 99.0 98.7 99.0 98.9 98.6 98.8 98.8
A13 98.5 98.7 99.1 98.9 98.8 98.9 99.2 99.0 98.9 99.0
A14 98.8 98.9 98.7 99.0 98.9 99.4 99.6 99.6 99.3 99.5
A15 97.6 97.8 98.3 98.3 98.0 97.7 97.9 97.9 97.6 97.8
A16 99.2 99.3 99.4 99.2 99.3 99.4 99.2 99.2 99.1 99.2
A17 98.9 98.9 99.1 99.1 99.0 98.3 98.5 97.3 98.4 98.1
A18 97.9 97.6 97.9 97.5 97.7 98.6 97.6 97.7 97.3 97.8
A19 98.7 97.3 97.8 99.2 98.3 97.8 96.4 97.6 97.7 97.4
A20 99.1 99.3 99.3 98.7 99.1 97.3 98.6 98.2 98.3 98.1
B1 96.4 96.6 96.3 95.4 96.2 94.3 94.1 96.1 97.1 95.4
B2 99.8 99.1 99.1 99.2 99.3 99.5 99.5 99.6 99.5 99.5
B3 98.1 98.5 98.2 98.5 98.3 97.6 98.3 97.6 97.2 97.7
B4 97.0 96.6 97.6 96.3 96.9 96.6 95.9 97.2 95.5 96.3
B5 98.4 98.1 98.4 98.7 98.4 98.2 97.6 98.2 97.8 97.9
B6 98.3 98.4 97.8 97.7 98.0 98.3 96.9 97.5 97.9 97.7
B7 99.4 99.2 99.6 99.8 99.5 98.5 98.5 98.3 98.9 98.5
B8 99.4 99.2 99.3 99.2 99.3 97.1 98.7 98.4 97.6 97.9
B9 99.3 98.4 99.0 97.6 98.6 96.9 97.0 96.1 96.4 96.6
B10 99.3 99.1 99.1 99.4 99.2 99.0 98.2 98.6 98.2 98.5
B11 98.0 98.0 97.7 98.0 97.9 97.6 97.2 97.2 97.3 97.3
B12 98.9 98.8 99.1 99.2 99.0 98.7 97.3 98.6 97.8 98.1
B13 93.8 97.3 97.0 98.4 96.6 90.4 93.2 95.3 96.9 94.0
B14 97.8 97.6 93.6 95.3 96.1 96.3 97.8 90.2 95.8 95.0
B15 97.6 98.7 99.1 98.9 98.5 98.1 98.7 98.0 99.0 98.4
B16 98.9 99.1 98.9 99.0 99.0 98.9 97.7 98.1 98.4 98.3
B17 99.3 99.4 99.4 99.2 99.3 98.2 97.7 98.3 98.6 98.2
B18 96.1 95.7 95.4 97.1 96.1 98.6 97.3 95.6 97.2 97.2
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predicted, FEV1/FVC = 76%). Interobserver agreement for 
respective image segmentations is shown in yellow, while 
disagreement between observers is shown in green. There is 
a high degree of spatial overlap between individual observer 
segmentations, with disagreement most prominent toward the 
peripheral lung slices. Figure 4B shows an equivalent com-
bined segmentation data set from a different participant (A6: 
34-year-old male; FEV1 = 113% predicted, FVC = 118% pre-
dicted, FEV1/FVC = 79%), in whom the discrepancy between 
observer segmentations (green) is more apparent. The Dice 
similarity coefficient, calculated as a measure of interobserver 
agreement across all 19F-MR image segmentations performed, 
demonstrated a high mean (SD) value of 0.97 (0.02).
3.3 | Comparison between sites
Image quality was of a sufficient standard across the two study 
sites to determine %VV values using the semi-automated seg-
mentation software, with comparable SNR achieved between 
F I G U R E  3  A, Representative 19F-MR ventilation images (coronal views) from a healthy participant, acquired during a 13.4-second breath-
hold scan following three deep breaths of a 79% PFP/21% oxygen gas mixture. The original magnitude image is displayed without any image 
processing or thresholding applied. An SNR of 13.5 was measured in a central lung slice of this image. B, Combined 1H and 19F-MR ventilation 
images (colored, orthogonal views) in the same participant, showing homogeneous gas distribution throughout the lung fields
F I G U R E  4  Combined 19F image segmentations performed independently by two observers, showing agreement (yellow) and disagreement 
(green) between respective segmentations. A, Example of close agreement in segmentations performed by the two observers (Dice similarity 
coefficient = 0.98), in which discrepancy is confined primarily toward the anterior slices. B, Example of greater discrepancy in segmentations 
performed by the two observers (Dice similarity coefficient = 0.93), in which more widespread differences are visible
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the respective study sites (mean SNRSiteA = 14.8 [2.5]; range = 
8.4-19.8; mean SNRSiteB = 13.9 [4.0]; range = 6.5-25.4). An 
independently sampled t-test revealed no evidence of a differ-
ence in SNR values between study sites (P = .11).
The %VV measurements, averaged across both observers 
to provide a single value per participant, were compared be-
tween the two study sites. An independently sampled t-test 
found no evidence of a difference in %VV values between 
the two study sites (P = .09), in which the mean %VV was 
98.3 (0.6)% (range = 97.1-99.3%) for site A, and 97.7 (1.3)% 
(range = 95.3-99.4%) for site B, respectively.
3.4 | Intraparticipant agreement
The SD around the mean of the four within-participant 
%VV measurements were meanobserver1 = 98.2% (SD = 0.4, 
range = 0.0-1.7) and meanobserver2 = 97.8% (SD = 0.5, range = 
0.0-2.9), measured by observers 1 and 2, respectively.
The spread of the four intraparticipant SNR measure-
ments around the mean value were mean SNRSiteA = 14.8 
(SD = 1.2, range = 0.4-2.3) and mean SNRSiteB = 13.9 (SD = 
1.2, range = 0.3-2.5).
4 |  DISCUSSION AND 
CONCLUSIONS
This study investigated the ability of 19F-MRI of inhaled PFP 
to provide quantitative measures of pulmonary ventilation, 
demonstrating good same-day reproducibility of %VV meas-
urements in a cohort of healthy participants. This work builds 
on a growing literature base surrounding the use of PFP as a 
potentially viable alternative to HP-MRI for human ventila-
tion imaging.
A goal of this study was to establish the technical feasibil-
ity of performing 19F-MR ventilation imaging across different 
study sites, while maintaining reproducibility of data acqui-
sition. We have successfully implemented a 19F-MR imaging 
protocol to acquire ventilation images from 38 healthy par-
ticipants at two research centers with sufficient image quality 
and SNR to determine %VV measurements. The %VV and 
its counterpart, ventilation defect percentage (equal to 100% 
minus %VV), are well-established metrics within the HP-
MRI literature, providing quantitative volume-independent 
measures that are sensitive to pathology and therapeutic re-
sponse.7,8 Our findings indicate a high degree of consistency 
in calculated %VV values across all study participants, with 
a low coefficient of variation between respective 19F-MR ac-
quisitions. It should be noted, however, that statistical assess-
ment of %VV values in a cohort of healthy participants will 
inevitably be skewed toward the upper end of the %VV scale 
(and ventilation defect percentage calculations from the data 
would be equivalently biased).
The ICCs we report are slightly lower than values previously 
published for 129Xe and 3He.7,9,11 However, ICCs are determined 
by the values of the between-acquisition and between-observer 
components of variance relative to the between-participant 
component of variance. There was little variation in %VV val-
ues measured in our cohort of healthy participants compared 
with previously reported studies,7,9 with most of our partici-
pants demonstrating %VV values between 97% and 99%. As 
such, the relatively modest ICC values observed in our study 
likely reflect the marked homogeneity of our particular cohort, 
rather than diminished reproducibility per se. The similarity of 
within-participant %VV values between observers (98.2% and 
97.8% for observer 1 and 2, respectively), and the small intra-
participant SDs around these values (0.4 and 0.5, respectively), 
support the reproducibility of this technique. Moreover, the 
high degree of interobserver consistency and precision in cal-
culated %VV values adds weight to the ability of our approach 
to provide reliable measures of pulmonary ventilation in a large 
group of healthy participants. Downstream application of these 
methods in patient cohorts will be beneficial in determining the 
capability of 19F-MRI across a broader spectrum of ventilation 
defect severities.
Formal evaluation of the safety of inhaled PFP (eg, 
through a clinical trial of an investigational medicinal 
product) was beyond the scope of this study. Nonetheless, 
our work adds weight to the growing body of evidence 
surrounding the use of PFP for human ventilation imag-
ing.18,19,22 To the best of our knowledge, this is the largest 
reported study to date involving 19F-MRI of inhaled PFP. 
In total, 200 19F-MRI scans were performed on the 40 par-
ticipants recruited to the study. Each acquisition consisted 
of three deep breaths of a 79% PFP/21% oxygen gas mix-
ture. We observed no adverse events relating to gas inha-
lation, with no effect on participant heart rate or oxygen 
saturation (summarized in Table 3). This has implications 
for performing larger clinical studies, including future mul-
ticenter trials involving patients with respiratory disease, 
which will be crucial in establishing suitability of this ap-
proach for wider clinical use.
There were some limitations to our study. Notably, 2 
participants were excluded from image analysis due to 
poor compliance with breathing instructions, which af-
fected the quality of acquired ventilation images. In both 
of these cases, at least one of the four gas inhalation ses-
sions was characterized by a failure to achieve maximal 
inspiration, which did not comply with the coached pro-
tocol. This resulted in images with a dearth of signal in 
combination with a substantial reduction in measured lung 
volume. Adherence to correct breathing instructions is cru-
cial to maintaining reproducibility of image acquisitions. 
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Importantly, our PFP inhalation protocol differs with HP-
MRI ventilation imaging, which typically involves a single 
inhalation of a small, fixed volume of gas. The sensitivity 
of inhaled PFP to changes in lung inflation level has previ-
ously been reported40 and underpins the specific breathing 
protocol used in this study (ie, three deep wash-in breaths 
of gas, followed by a breath-hold at maximum inspiration). 
This contrasts with the inhalation protocol reported by 
Couch et al, who used relaxed tidal wash-in breaths, up to 
a cumulative 5 L, followed by a fixed (1 L) inhalation and 
breath hold.18 Nonetheless, by adopting this approach, the 
PFP wash-in volume may be standardized relative to the 
volume of maximal inhalation achievable by each partici-
pant, rather than adopting a fixed wash-in volume regard-
less of lung capacity. Our breathing protocol was therefore 
developed to achieve substantial replacement of air by PFP 
within the lungs, maximizing the SNR in ventilated regions 
and facilitating reproducibility of scan acquisitions. At the 
same time, the brevity of this wash-in breathing protocol 
was designed to preserve the discernibility of poorly ven-
tilated lung regions that is characteristic of patients with 
obstructive airways disease (data from pilot and ongoing 
studies not shown). Importantly, in the 38 participants who 
performed breathing maneuvers as instructed, we demon-
strated good reproducibility of %VV measurements.
The use of advanced MR coil hardware (eg, array coils)41 
may help to improve the overall SNR of 19F-MR images, as 
well as address the spread of SNR values observed between 
participants. This may, in part, stem from differences in coil 
loading associated with varying body habitus, in addition to 
differences in breathing efficacy relating to the gas wash-in 
protocol. Moreover, improved coil design may mitigate the 
tendency for spatially variable signal inhomogeneities (with 
slight signal dropoff particularly apparent toward the out-
ermost anterior slices). Although this potentially reflects a 
degree of physiological ventilation heterogeneity, it is more 
likely the result of local field inhomogeneity arising from 
coil–scanner interaction. Segmentation of these particular 
slices does not, however, appear to have a substantial effect 
on global %VV measurements.
The ability to breathe PFP continuously over several re-
spiratory cycles has recently been used as an alternative to 
static breath-hold imaging,22 enabling dynamic image ac-
quisition during free breathing. This approach plays to the 
strengths of 19F-MRI of PFP compared with HP-MRI, in 
which the thermally polarized gas does not exhibit the irre-
coverable loss of signal over a dynamic imaging series that 
is unavoidable with hyperpolarized tracer gases (ie, 3He and 
129Xe). Dynamic imaging reduces the requirement to follow 
a rigid inhalation protocol and offers potential advantages for 
imaging of patients with respiratory disease or younger chil-
dren who may not be able to tolerate breath-hold maneuvers. 
The repeatability of dynamic gas wash-out measurements 
in patients with chronic obstructive pulmonary disease has 
recently been reported.33 Nonetheless, given the widespread 
use of %VV measurements in HP-MRI literature, our study 
provides an important benchmark from which to determine 
the utility of static 19F-MR ventilation imaging in preparation 
for performing future patient studies.
We report for the first time an evaluation of %VV mea-
surements acquired by 19F-MRI of inhaled PFP, demon-
strating good same-day reproducibility in a large number of 
healthy participants. The successful implementation of scan 
procedures across two different study sites provides a firm 
foundation from which to compare image quality and vari-
ability in patients with respiratory disease, including applica-
tion to dynamic ventilation imaging.
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